Payam Tristani-Firouzi, MD


  • English

Academic Information

  • Departments: Dermatology - Associate Professor (Clinical)

Board Certification

  • American Board of Dermatology (Dermatology)

Academic Office Information

  • 801-581-6465
  • School of Medicine
    30 N 1900 E, Room: 4B454
    Salt Lake City, UT 84132

Academic Bio

Dr. Tristani-Firouzi is an Associate Professor of Dermatology at the University of Utah School of Medicine. She is the Director of the Department of Dermatology’s Laser and Cosmetic Clinic where she oversees the clinical operations. She is also a member of the strategic planning of the department. Dr. Tristani-Firouzi is highly active with resident education and received the Resident Teacher of the Year award in 2011. Dr. Tristani-Firouzi is an author of numerous publications in dermatologic surgery. She has lectured both regionally and nationally. She is an active member of numerous local and national professional associations.Dr. Tristani-Firouzi’s primary clinical expertise relates to the management of patients’ with skin cancers. She is fellowship-trained in Mohs Micrographic Surgery which is a highly specialized technique used to remove skin cancers with the highest cure rates. As the director of the Dermatology Laser Clinic, she is highly skilled in a variety of laser and cosmetic surgical procedures to treat patients with both medical and cosmetic concerns. She is particularly interested in treating patients who are at high risk for developing skin cancers.

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Mohs Micrographic Surgery
Residency University of Utah School of Medicine
Fellowship University of Utah School of Medicine
Internship University of Utah School of Medicine
Internal Medicine
Professional Medical University of Minnesota
Graduate Training University of Minnesota
Laboratory Medicine and Pathology
Undergraduate University of Minnesota
Medical Technology

Selected Publications

Journal Article

  1. Hadley J, Tristani-Firouzi P, Hull C, Florell S, Cotter M, Hadley M (2012). Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses. Dermatol Surg, 38(5), 722-7.
  2. Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM (2012). A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol, 148(5), 592-6.
  3. Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50.
  4. Foo CW, Tristani-Firouzi P (2011). Topical modalities for treatment and prevention of postsurgical hypertrophic scars. Facial Plast Surg Clin North Am, 19(3), 551-7.
  5. Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case Series of Multiply Recurrent Reactive Keratoacanthoma Developing at Surgical Margins. Dermatol Surg, 35(12), 2019-24.
  6. Duffy KL, McKenna JK, Hadley ML, Tristani-Firouzi P (2009). Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size. Dermatol Surg, 35(1), 30-3.
  7. Duffy KL, Florell SR, Tristani-Firouzi P, Bowen AR, Hadley ML (2009). Syringocystadenomatous-like change adjacent to a squamous cell carcinoma: Potential Mohs Micrographic Surgery pitfall. Dermatol Surg, 35(3), 519-22.